Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507647046/en/TNF-Pharmaceuticals-and-Renova-Health-Report-Positive-Results-in-Identifying-Targets-for-Treating-TNF-Driven-Inflammation-in-Patients-Receiving-GLP-1-Agonists
22 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250422412441/en/TNF-Pharmaceuticals-and-Renova-Health-Utilize-AI-to-Accelerate-Drug-Development
16 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250416886460/en/TNF-Pharmaceuticals-Delivers-Platform-Presentation-of-Oral-TNF-Alpha-Inhibitor-Isomyosamine-at-British-Geriatrics-Societys-Spring-Meeting-2025
17 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250317910784/en/TNF-Pharmaceuticals-Delivers-Podium-Presentation-of-Novel-Oral-TNF-Alpha-Inhibitor-at-Premier-International-Conference-on-Frailty-and-Sarcopenia
05 Mar 2025
// BUSINESSWIRE
25 Feb 2025
// BUSINESSWIRE
ABOUT THIS PAGE